Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 4,941,457 |
|
|||||
| News | (3) | ||||||
| Day High | 150.80 | Low High |
|||||
| Day Low | 137.52 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 4.95 | 3.47% | 147.50 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 139.75 | 137.52 | 150.80 | 147.82 | 142.55 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 80,942 | 4,941,457 | $ 146.89 | $ 725,863,121 | - | 62.55 - 170.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:39 | 1 | $ 147.50 | USD |
Moderna (MRNA) Options Flow Summary
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 56.48B | 382.07M | - | 6.85B | -4.71B | -12.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 161.64 | 164.725 | 137.52 | 148.46 | 5,998,487 | -14.14 | -8.75% |
| 1 Month | 125.00 | 170.47 | 116.7317 | 143.65 | 4,773,580 | 22.50 | 18.00% |
| 3 Months | 103.44 | 170.47 | 97.00 | 122.21 | 4,089,466 | 44.06 | 42.59% |
| 6 Months | 79.56 | 170.47 | 73.25 | 106.91 | 4,519,440 | 67.94 | 85.39% |
| 1 Year | 131.00 | 170.47 | 62.55 | 104.21 | 4,187,348 | 16.50 | 12.60% |
| 3 Years | 189.00 | 497.17 | 62.55 | 220.24 | 6,833,208 | -41.50 | -21.96% |
| 5 Years | 20.79 | 497.17 | 11.54 | 147.60 | 8,909,820 | 126.71 | 609.48% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
